Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Core One Labs Inc C.COOL

Alternate Symbol(s):  CLABF

Healthcare Cannabis
Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. Its subsidiary, Vocan Biotechnologies Inc., has developed and filed for patent protection of a proprietary psilocybin production system using engineered bacteria. It is also the holder of four provisional patents for the development of psychedelic-based pharmaceutical formulations targeting neurological and mental health disorders, under its subsidiary Akome Biotech Ltd., and three provisional patents under its other subsidiary, Awakened Biosciences Inc., for additional synthetic technologies for psilocybin and psilocin production methods. It also holds an interest in four medical clinics, which maintain a combined database of more than 275,000 patients.


CSE:COOL - Post by User

Core One Labs Inc > COOL now ICE
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(928)
•••
Comment by CancerSlayeron Apr 15, 2021 4:58pm
116 Views
Post# 33005321

RE:RE:RE:COOL now ICE

RE:RE:RE:COOL now ICE
CancerSlayer wrote:

 

kkkrrr wrote: ???? it doesn't matter because the marketcap is the same before and after a consolidation of shares ...     what matters is a nasdaq-listing possibly requires a minimum marketcap. But i'am nut sure about this...    first we need substancial news about its products from this company.. 

 

We at least reduced dilution by almost 3 million shares (increasing shareholder value/sp today) by the rescission of that bad CGOC (now PBIC) deal.  Now if they would only reconsider the Nasdaq up-listing & stay focused on product development/revenue generation.  Wouldn't prefer a small share buyback before up-listing ; )....would do more to boost the sp & confidence in this company. 


 

Should read:  WOULD prefer...

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities